AZ-002 (Staccato Alprazolam)
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 04/10/2020
Pipeline Type
New Drugs in Development
Phase Of Development
Phase 2
Sponsors and Collaborators
Engage Therapeutics
Mechanism of Action
GABA
Mechanism Description
Benzodiazepene (XANAX) that can be inhaled
Populations Tested In
Acute Repetitive Seizures
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
AEDD 2019
Location of Clinical Trials
61 sites: Arizona, Arkansas, California, Connecticut, District of Columbia, Florida, Georgia, Hawaii, Illinois, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oregon, Pennsylvania, Texas, Utah, Virginia, Washington, Australia, Jamaica,